Home › Bronchiolitis Obliterans Syndrome › Washington
Bronchiolitis Obliterans Syndrome clinical trials in Washington
11 studies for Bronchiolitis Obliterans Syndrome are looking for participants at sites in Washington.
Cities in Washington
Axatilimab for Sclerotic Chronic Graft-versus-Host Disease
- Fred Hutch/University of Washington Cancer Consortium, Seattle
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07011810A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
- Fred Hutchinson Cancer Research Center- Site Number : 8400002, Seattle
RecruitingPhase 2
Ages 1 to 18 · All sexes · Updated Sep 22, 2026 · NCT07116031Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease
- Fred Hutch/University of Washington Cancer Consortium, Seattle
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT05996627A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
- Fred Hutchinson Cancer Research Center, Seattle
RecruitingPhase 2
Ages 2 to 17 · All sexes · Updated Sep 15, 2026 · NCT07124078Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
- Seattle Childrens Hospital, Seattle
RecruitingPhase 2
Ages 1 to 18 · All sexes · Updated Sep 2, 2026 · NCT07354074Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
- Fred Hutchinson Cancer Research Center, Seattle
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT05919511Dental Cleaning to Prevent Chronic Graft-Versus-Host Disease
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Recruiting
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT07535008A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
- Fred Hutchinson Cancer Research Center, Seattle
RecruitingPhase 2
Ages 2 and older · All sexes · Updated Jun 16, 2026 · NCT04710576BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
- Fred Hutchinson Cancer Center, Seattle
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT05922761A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- Fred Hutchinson Cancer Research Center, Seattle
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 20, 2026 · NCT06615050Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- Fred Hutchinson Cancer Center, Seattle
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Apr 15, 2025 · NCT06462365From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.